Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Performance of a genetic risk score for CKD stage 3 in the general population.

O'Seaghdha CM, Yang Q, Wu H, Hwang SJ, Fox CS.

Am J Kidney Dis. 2012 Jan;59(1):19-24. doi: 10.1053/j.ajkd.2011.08.030. Epub 2011 Oct 13.

2.

Genetic risk score and risk of stage 3 chronic kidney disease.

Ma J, Yang Q, Hwang SJ, Fox CS, Chu AY.

BMC Nephrol. 2017 Jan 19;18(1):32. doi: 10.1186/s12882-017-0439-3.

3.

Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.

O'Seaghdha CM, Tin A, Yang Q, Katz R, Liu Y, Harris T, Astor B, Coresh J, Fox CS, Kao WH, Shlipak MG.

Am J Kidney Dis. 2014 Jan;63(1):16-22. doi: 10.1053/j.ajkd.2013.06.015. Epub 2013 Aug 7.

4.

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.

O'Seaghdha CM, Hwang SJ, Bhavsar NA, Köttgen A, Coresh J, Astor BC, Fox CS.

Am J Kidney Dis. 2011 Jun;57(6):841-9. doi: 10.1053/j.ajkd.2010.11.022. Epub 2011 Feb 3.

5.

Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.

Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS.

Am J Kidney Dis. 2008 Jul;52(1):39-48. doi: 10.1053/j.ajkd.2008.03.003. Epub 2008 Apr 28.

6.

Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.

Wuttke M, Wong CS, Wühl E, Epting D, Luo L, Hoppmann A, Doyon A, Li Y; CKDGen Consortium, Sözeri B, Thurn D, Helmstädter M, Huber TB, Blydt-Hansen TD, Kramer-Zucker A, Mehls O, Melk A, Querfeld U, Furth SL, Warady BA, Schaefer F, Köttgen A.

Nephrol Dial Transplant. 2016 Feb;31(2):262-9. doi: 10.1093/ndt/gfv342. Epub 2015 Sep 28.

7.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA; CKD Biomarker Consortium and the CRIC Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):68-76. doi: 10.1053/j.ajkd.2016.01.015. Epub 2016 Mar 3.

8.

Arterial Stiffness and Decline in Kidney Function.

Sedaghat S, Mattace-Raso FU, Hoorn EJ, Uitterlinden AG, Hofman A, Ikram MA, Franco OH, Dehghan A.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2190-7. doi: 10.2215/CJN.03000315. Epub 2015 Nov 12. Review.

9.

Cognitive Impairment and Progression of CKD.

Kurella Tamura M, Yaffe K, Hsu CY, Yang J, Sozio S, Fischer M, Chen J, Ojo A, DeLuca J, Xie D, Vittinghoff E, Go AS; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):77-83. doi: 10.1053/j.ajkd.2016.01.026. Epub 2016 Mar 10.

10.

Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.

Ma RC, Tam CH, Wang Y, Luk AO, Hu C, Yang X, Lam V, Chan AW, Ho JS, Chow CC, Tong PC, Jia W, Ng MC, So WY, Chan JC.

JAMA. 2010 Aug 25;304(8):881-9. doi: 10.1001/jama.2010.1191.

PMID:
20736472
11.

Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.

Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators.

Am J Kidney Dis. 2014 Feb;63(2):236-43. doi: 10.1053/j.ajkd.2013.08.028. Epub 2013 Oct 30.

12.

APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.

Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM.

Am J Kidney Dis. 2015 Jun;65(6):889-98. doi: 10.1053/j.ajkd.2015.02.329. Epub 2015 Apr 24.

13.

Genotype score in addition to common risk factors for prediction of type 2 diabetes.

Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D'Agostino RB Sr, Cupples LA.

N Engl J Med. 2008 Nov 20;359(21):2208-19. doi: 10.1056/NEJMoa0804742. Erratum in: N Engl J Med. 2009 Feb 5;360(6):648.

14.

Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.

Hishida A, Wakai K, Naito M, Suma S, Sasakabe T, Hamajima N, Hosono S, Horita M, Turin TC, Suzuki S, Kairupan TS, Mikami H, Ohnaka K, Watanabe I, Uemura H, Kubo M, Tanaka H; J-MICC Study Group.

Lipids Health Dis. 2014 Oct 14;13:162. doi: 10.1186/1476-511X-13-162.

15.

Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.

Kubo Y, Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kikuchi K, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Maruyama S.

PLoS One. 2017 Oct 10;12(10):e0185476. doi: 10.1371/journal.pone.0185476. eCollection 2017.

16.

Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort.

Pani A, Bragg-Gresham J, Masala M, Piras D, Atzeni A, Pilia MG, Ferreli L, Balaci L, Curreli N, Delitala A, Loi F, Abecasis GR, Schlessinger D, Cucca F.

J Am Soc Nephrol. 2014 Jul;25(7):1533-44. doi: 10.1681/ASN.2013060591. Epub 2014 Feb 7.

17.

Elevated galectin-3 precedes the development of CKD.

O'Seaghdha CM, Hwang SJ, Ho JE, Vasan RS, Levy D, Fox CS.

J Am Soc Nephrol. 2013 Sep;24(9):1470-7. doi: 10.1681/ASN.2012090909. Epub 2013 Jun 13.

18.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.

JAMA. 2011 Apr 20;305(15):1545-52. doi: 10.1001/jama.2011.468. Epub 2011 Apr 11.

19.

Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

O'Seaghdha CM, Hwang SJ, Holden R, Booth SL, Fox CS.

Am J Nephrol. 2012;36(1):68-77. doi: 10.1159/000339005. Epub 2012 Jun 20.

20.

A multi-marker approach to predict incident CKD and microalbuminuria.

Fox CS, Gona P, Larson MG, Selhub J, Tofler G, Hwang SJ, Meigs JB, Levy D, Wang TJ, Jacques PF, Benjamin EJ, Vasan RS.

J Am Soc Nephrol. 2010 Dec;21(12):2143-9. doi: 10.1681/ASN.2010010085. Epub 2010 Oct 21.

Supplemental Content

Support Center